Searched for
KURKUMBH FACILITY
Cipla expects to commence supplies to US from China plant later this yearCipla plans to start supplying from its China facility to the US market by the second half of the current fiscal year, following USFDA appr...- USFDA issues Form 483 with 1 inspectional observation to Cipla's Kurkumbh unitA routine current Good Manufacturing Practices (cGMP) inspection was conducted by the USFDA at the company's manufacturing facility at Kurk...
- Cipla adds capacity of captive renewable energy power plant in Maharashtra, KarnatakaThe company had commissioned 30 MWp solar project in Maharashtra's Tuljapur in January 2021, which it has further added 16 MWp of solar cap...
- Glenmark Life IPO subscribed nearly 31 times on final dayMost analysts are positive on the company's future prospects and suggest subscribing to the issue. They believe the company, which is a spi...
- Glenmark Life Sciences IPO subscribed 4 times on Day 2Most analysts are positive on the company's future prospects and suggest subscribing to the issue. They believe the company, which is a spi...
- Glenmark Life Sciences IPO sails through on Day 1Most analysts are positive on the company's future prospects and suggest subscribing to the issue. They believe the company, which is a spi...
- Glenmark Life Sciences IPO opens today: Should you subscribe?Considering the FY-21 adjusted EPS of Rs 28.69 on post issue basis, the upper price band of Glenmark Life Sciences IPO implies a P/E of 25....
- Cipla recalls 7,228 bottles of overactive bladder treatment drug in AmericaAs per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or...
- Clean Science and Technology raises Rs 464 cr from anchor investorsAxis Capital, JM Financial and Kotak Mahindra Capital are the merchant bankers to the issue. The equity shares of the company will be liste...
- Speciality chem firm Clean Science and Tech planning Rs 1,400 cr IPOAxis Capital, JM Financial and Kotak Mahindra Capital company are likely to lead the issue as merchant bankers.
- Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in USThe drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 4...
- Henkel Adhesives invests Rs 400 crores in its new production unit in India“The jobs are around 320 plus for the new facility. The unit is automated to every extent, therefore we have all skilled Jobs in there. And...
- Cipla seeks adoption of pragmatic IPR policyCipla has sought adoption of a pragmatic Intellectual Property Rights (IPR) policy including in-licensing within the present framework of i...
- Alkyl Amines plans to set up methylamine unit at Dahejr Alkyl Amines Chemicals is planning to set up a methylamine manufacturing facility at Dahej in Gujarat with an estimated investment of Rs ...
- Cipla hopeful of achieving 12-15 per cent revenue growth in FY13Pharma major Cipla Ltd today said it is hopeful of achieving 12-15 per cent revenue growth in the current financial year.
- Cipla to invest Rs 500 cr to set up API facilitiesCipla Ltd plans to invest Rs 500 crore for setting up an active pharmaceutical ingredients (API) facilities at Patalganga, Bengaluru and Ku...
- Reliance Retail to launch an in-house ready-to-eat food brandReliance Retail plans to launch an in-house ready-to-eat food brand in the next 2-3 months and has partnered a foreign firm for the technic...
- Cipla promoters not selling out,Co plans to scale up revenuesPharma major Cipla on Thursday said it is expecting to scale up its revenue by over six times to Rs 15,000-20,000 crore.
- Cipla clocks Rs 275 cr profit in Q4; to acquire two plantsCipla today said its net profit rose by 8.93 per cent to Rs 275.53 crore for Q4.
- CRISIL assigns IPO grade 4/5 to Glenmark GenericsCRISIL has assigned IPO Grade 4/5 to the proposed IPO of Glenmark Generics Ltd, which indicates that the fundamentals of the IPO are above ...
Load More
